Frontmatter.
- Published in:
- Biological Chemistry, 2024, v. 405, n. 7/8, p. i, doi. 10.1515/hsz-2024-frontmatter7-8
- Publication type:
- Article
Works matching IS 14316730 AND DT 2024 AND VI 405 AND IP 7/8
Results: 8
1
2
Highlight: new developments in immunoengineering.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
3
Development of an enabling platform biotechnology for the production of proteins.
- Published in:
- Biological Chemistry, 2024, v. 405, n. 7/8, p. 471, doi. 10.1515/hsz-2023-0376
- By:
- Publication type:
- Article
4
Bovine ultralong CDR-H3 derived knob paratopes elicit potent TNF-α neutralization and enable the generation of novel adalimumab-based antibody architectures with augmented features.
- Published in:
- Biological Chemistry, 2024, v. 405, n. 7/8, p. 461, doi. 10.1515/hsz-2023-0370
- By:
- Publication type:
- Article
5
Unpaired cysteine insertions favor transmembrane dimerization and induce ligand-independent constitutive cytokine receptor signaling.
- Published in:
- Biological Chemistry, 2024, v. 405, n. 7/8, p. 531, doi. 10.1515/hsz-2023-0344
- By:
- Publication type:
- Article
6
Advances in preclinical TCR characterization: leveraging cell avidity to identify functional TCRs.
- Published in:
- Biological Chemistry, 2024, v. 405, n. 7/8, p. 517, doi. 10.1515/hsz-2023-0341
- By:
- Publication type:
- Article
7
Better safe than sorry: dual targeting antibodies for cancer immunotherapy.
- Published in:
- Biological Chemistry, 2024, v. 405, n. 7/8, p. 443, doi. 10.1515/hsz-2023-0329
- By:
- Publication type:
- Article
8
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies.
- Published in:
- Biological Chemistry, 2024, v. 405, n. 7/8, p. 485, doi. 10.1515/hsz-2023-0317
- By:
- Publication type:
- Article